Breaking News, Financial News

Financial Report: Hospira 1Q09

Global Specialty Injectables revenue was down 7.5% to 429.7 million, with Europe, Middle East & Africa sales down 26% to $57.6 million and the Americas down 2% to $333.1 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hospira 1Q09 1Q Revenues: $859.7 million (-3%) 1Q Earnings: $114.7 million (earnings were $65.4 million in 1Q08) Comments: Global Specialty Injectables revenue was down 7.5% to $429.7 million, with Europe, Middle East & Africa sales down 26% to $57.6 million and the Americas down 2% to $333.1 million. Other Global Pharma revenues were $169.1 million in the quarter (+4%). Growth in Other Pharma in the Americas segment and overall performance in Medication Management Systems (MMS), we...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters